Cu-Zn super oxide dismutase as a potential antifibrotic drug for hepatitis C related fibrosis

Biomedicine and Pharmacotherapy

Volumn 60, Issue 1, 2006, Pages 1-4

  Emerit, Jacques ^a   Samuel, Didier ^b   Pavio, Nicole ^c  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b HÔPITAL PAUL BROUSSE   (France)

^c INSERM   (France)

Author keywords

Cu Zn SOD (SOD1); Hepatocellularcarcinoma; Liver fibrosis; Stellate cells; TGF 1

Indexed keywords

ALPHA TOCOPHEROL; ANTIFIBROTIC AGENT; COPPER ZINC SUPEROXIDE DISMUTASE; CORE PROTEIN; CYTOKINE; HEPATITIS C ANTIBODY; MESSENGER RNA; PEGINTERFERON; PROTEIN; RIBAVIRIN; TRANSFORMING GROWTH FACTOR BETA1;

ANTIVIRAL ACTIVITY; CLINICAL TRIAL; COCULTURE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DOWN REGULATION; DRUG EFFICACY; DRUG POTENCY; DRUG TARGETING; EXPERIMENTAL MODEL; FIBROBLAST; FIBROBLAST CULTURE; FIBROTEST; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LABORATORY TEST; LIPID PEROXIDATION; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FIBROSIS; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RADIATION INJURY; REVIEW; RISK ASSESSMENT; SCORING SYSTEM; SIGNAL TRANSDUCTION; SKIN CULTURE; STATISTICAL SIGNIFICANCE; SWINE; TRANSGENIC MOUSE; VALIDATION PROCESS;

EID: 29244484242     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2005.09.002     Document Type: Short Survey

References (33)

1. S.L. Friedman Liver fibrosis J. Hepatol. 38 2003 S38 S53
2. T. Poynard, V. Ratziu, F. Charlotte, Z. Goodman, J. McHutchison, and J. Albrecht Rates and risk factors of liver cirrhosis progression in patients with chronic hepatitis C J. Hepatol. 34 2001 730 739
3. H. Tsukuma, T. Hiyama, S. Tanaka, M. Nakao, T. Yabuuchi, and T. Kitamura Risk factors for hepatocellular carcinoma among patients with chronic hepatic diseases N. Engl. J. Med. 328 1993 1797 1801
4. G. Perlemuter, P. Letteron, F. Carnot, F. Zavala, D. Pessayre, B. Nalpas, and C. Bŕchot Alcohol and hepatitis C virus core protein additively increase lipid peroxidation and synergistically trigger hepatic cytokine expression in a transgenic mouse model J. Hepatol. 39 2003 1023 1027
5. M. Martin, J.L. Lefaix, and S. Delanian TGFβ1 and radiation fibrosis: a master switch and a specific therapeutic target Int. J. Radiat. Oncol. Biol. Phys. 47 2000 277 290
6. G.C. Blobe, W.P. Schiemann, and H.F. Lodish Role of TGFβ in human diseases N. Engl. J. Med. 342 2000 1350 1358
7. A. Castilla, J. Prieto, and N. Fausto TGFβ1 and α interferon in chronic liver disease N. Engl. J. Med. 324 1991 933 940
8. J. Emerit, A.M. Michelson, H.G. Robert, G. Comette, R.A. Guerin, J. Blondon, and M. Bertrand Traitement par la SOD de 2 cas de scĺrose radio-induite Sem. Hop. Paris 59 1983 277 281
9. S. Delanian, F. Baillet, J. Huart, J.L. Lefaix, C. Maulard, and M. Housset Successful treatment of radiation-induced fibrosis using liposomal Cu,Zn-SOD: clinical trial Radiother. Oncol. 32 1994 12 20
10. M. Martin, J.L. Lefaix, P. Pinton, F. Crechet, and F. Daburon Temporal modulation of TGF-β and β-actin gene expression in pig skin and muscular fibrosis after ionizing radiation Radiat. Res. 134 1993 63 70
11. W.A. Border, and N.A. Noble TGFβ in tissue fibrosis N. Engl. J. Med. 331 1994 1286 1292
12. S. Wahl M. TGFβ in inflammation: a cause and a cure J. Clin. Immun. 12 1992 61 73
13. S.M. Wahl Inflammation and growth factors J. Urol. 157 1997 303 305
14. S. Dooley, B. Delvoux, B. Lahme, K. Mangasser-Stephan, and A.M. Gressner Modulation of TGFβ1 response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts Hepatology 31 2000 1094 1106
15. H. Taniguchi, M. Kato, M. Otsuka, T. Goto, H. Yoshida, and M. Omata Hepatitis C virus core protein upregulates TGF-β1 transcription J. Med. Virol. 72 2004 52 59
16. R. Bataller, Y.-H. Paik, J.N. Lindquist, J.L. Lemaster, and D.A. Brenner Hepatitis C virus core and nonstructural proteins induce fibrogenic effects in hepatic stellate cells Gastroenterology 126 2004 529 540
17. J.Y. Shin, S.K. Yoon, J.S. Wang, W. Hur, J.S. Ryu, S.H. Bae, and J.Y. Choi The role of hepatitis C virus core protein in liver fibrogenesis Korean J. Gastroenterol. 42 2003 400 408
18. S.K. Jain, P.W. Pemberton, A. Smith, R.F.T. McMahon, and P.C. Burrows Oxidative stress in chronic hepatitis C J. Hepatol. 36 2002 805 811
19. A. Casini, E. Ceni, R. Salzano, P. Biondi, M. Parola, and A. Galli Neutrophil derived superoxide anion induces lipid peroxidation and stimulates collagen synthesis in human hepatic stellate cells Hepatology 25 1997 367
20. N. Nieto, S.L. Friedman, P. Greenwel, and A.L. Cederbaum CYP 2EI mediated oxidative stress induces collagen type I expression in rat hepatic stellate cells Hepatology 30 1999 987 996
21. G. Poli, and M. Parola Oxidative damage and fibrogenesis Free Rad. Biol. Med. 22 1997 287 305
22. G. Poli Pathogenesis of liver fibrosis; role of oxidative stress Mol. Aspects Med. 21 2000 49 98
23. G. Leonarduzzi, A. Scavazza, F. Biasi, E. Chiarpotto, S. Caamandola, S. Vogel, R. Dargel, and G. Poli The lipid peroxidation end product 4-hydroxy-2,3-nonenal up-regulate TGFβ1 expression in the macrophage lineage: a link between oxidative injury and fibrosclerosis FASEB J. 11 1997 851 857
24. M. Parola, R. Muraca, I. Dianzani, G. Barera, G. Leonarduzzi, P. Bendinelli, R. Picoletti, and G. Poli Vitamin E dietary supplementation inhibits TGFβ1gene expression in the rat liver FEBS. 308 1992 267 270
25. E.E. Powell, C.J. Edwards-Smith, J.L. Hay, A.D. Clouston, D.H. Crawford, and C. Shorthouse Host genetic factors influence disease progression in chronic hepatitis C Hepatology 31 2000 828 833
26. H. Eto, S. Biro, M. Miyata, H. Kaieda, H. Obata, K. Kihara, and C. Tei Angiotensin II type 1 receptor participates in extracellular matrix production Cardiovasc. Res. 59 2003 2000 2211
27. D.C. Rockey, and J.J. Chung Endothelin antagonism in experimental hepatic fibrosis J. Clin. Invest. 98 1996 1381 1388
28. N. Sanderson, V. Factor, P. Nagy, J. Kopp, P. Kondalah, L. Wakefield, A.B. Roberts, M.B. Sporn, and S.S. Thorgeirson Hepatic expression of mature TGFβ1in transgenic mice results in multiple tissue lesions Proc. Natl. Acad. Sci. USA 92 1995 2572 2576
29. R.I. Bechara, L.A.S. Brown, J. Roman, P.C. Joshi, and D.M. Guidot TGFβ1 expression and activation is increased in the alcoholic rat lung Am. J. Respir. Crit. Care Med. 170 2004 188 194
30. Esco Baron R., Efficacy of orgotein (SOD) in prevention of late side effects of pelvic irradiation: a randomized study, admitted for publication Int. J. Radiat. Oncol. Biol. Phys.
31. M.-C. Vozenin, V. Sivan, N. Gault, C. Renard, C. Geffrotin, J.-L. Lefaix, M. Martin, and S. Delanian Antifibrotic action of Cu:Zn SOD is mediated by TGF-β1, repression and phenotic reversion of myofibroblasts Free Rad. Bio. Med. 30 2001 30 42
32. V. Soriano, L. Martin-Carbonaro, and J. Garcia-Samaniego Treatment of chronic hepatitis C; we must target the virus or liver fibrosis? AIDS 17 2003 751 753
33. S. Elchuri, T.D. Oberley, W. Qi, R.S. Eisenstein, L.J. Roberts, and H. Van Remmen Cu-Zn SOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life Oncogene 24 2005 367 380